Conavi Medical

6 articles with Conavi Medical

• Conavi Medical’s Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre

  4/28/2022

  Conavi Medical Inc. and Sunnybrook Health Sciences Centre, announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.

• Conavi Medical Announces Health Canada Approval of Novasight Hybrid System for Visualization During Coronary Angioplasty Procedures

  3/13/2019

  Recent randomized studies with existing IVUS systems have shown that intravascular imaging has the potential to significantly improve clinical outcomes during angioplasty and stenting.

• Conavi Medical Announces Clinical Use of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound and Optical Coherence Tomography Capabilities

  8/13/2018

  Conavi Medical is pleased to announce the first clinical use of the NovasightHybrid System, which enables simultaneous imaging of coronary arteries with both intravascular ultrasound and Optical Coherence Tomography.

• Conavi Medical Announces FDA 510(k) Clearance of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) Capabilities

  5/1/2018

  ConaviTM Medical Inc. (www.conavi.com) is pleased to announce that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its NovasightTM Hybrid System

• Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in China

  11/16/2017

  China Grand Pharmaceutical and Healthcare Holdings will serve as the exclusive distributor of its Foresight Intracardiac Echocardiography and Novasight Hybrid Intravascular Imaging systems in China, Hong Kong, Taiwan and Macau.

• Conavi Medical Welcomes Peter Wehrly To The Board Of Directors

  6/19/2017